Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Post by threefiftynineon Jun 10, 2020 8:23am
126 Views
Post# 31132232

----SPECULATION AND GUESSWORK---

----SPECULATION AND GUESSWORK---
Is alive and well both on here and ceo.ca. Everyone is an expert , but all they are experts at is guesswork and that unfortunately is also yours truly. Im at my 7th guess right now--guessing about phase1 funding pp's blah blah---but the harsh reality is that no-one is in the green with this rather strange investment . The Money was made by .10 cent warrant holders when the company secured its short -term future at highs of .335 based on nothing but pandemic hype. Now a private placement has surfaced and no apparent reason given so far by the ceo .We are now 50% of the timeline given as a closed deal with no approval by the TSXV or any news to retail shareholders with respect to pre-clinical trials since APRIL13th ---Yes I typed APRIL13th----Maybe time for all the speculative experts who post all things ISRAEL on ceo ca to give it a rest . The only one who knows about the future of this company are the insiders. NO ONE ELSE-At this time the money has made and profits cashed in by the smart people who saw the light . I eagerly will await news from this company but at this time I feel the ship has sailed and cancer testing will once again become this company's main vein and COVID19 will just become a fantastic opportunity they grasped with open arms and bandwagoned the chit out of it-----I will post on ceo and here once again after the ceo decides to actually communicate with the very retail investors who put 1.4 million dollars in to their coffers ---and they sailed off in to the night with wages, bonuses and all the other perks fully intact. glta ---359
<< Previous
Bullboard Posts
Next >>